(provisional)
Abad, C.; Karahoda, R.; Orbisová, A.; Kastner, P.; Heblík, D.; Kučera, R.; Portillo, R.; Štaud, F.*: Pathological shifts in tryptophan metabolism in human term placenta exposed to LPS or poly I:C. Biology of Reproduction, 2024, 110 (4), 722—738. JCR: IF23:3.1(Q2) AIS23:0.978(Q2) WOS:001146813400001 EID:2-s2.0-85191090127 PMID:38145492 DOI:10.1093/biolre/ioad181 OBD:647243»
Alfred, MA.; Lang, K.; Kirakci, K.; Stuzhin, P.; Zimčík, P.; Labuta, J.*; Nováková, V.*: Subphthalocyanines as fluorescence sensors for metal cations. Dalton Transactions, 2024, 53 (6), 2635—2644. JCR: IF23:3.5(Q2) AIS23:0.528(Q1) WOS:001142314500001 EID:2-s2.0-85182689675 PMID:38224238 DOI:10.1039/d3dt03839d OBD:655664»
Al-Hamdan, NS.; Hussain, A.; Kozlíková, M.; Alfred, MA.; Macháček, M.; Ganesan, A.; Zimčík, P.*; Makhseed, S.*: Enhanced photodynamic activity of asymmetric non-ionic Zn(II) phthalocyanine amphiphiles: Effect of molecular design on In vitro activity. Dyes and Pigments, 2024, 221 (January), art.111809. JCR: IF23:4.1(Q2Q2Q1) AIS23:0.505(Q2Q2Q1) WOS:001125412400001 EID:2-s2.0-85177859535 DOI:10.1016/j.dyepig.2023.111809 OBD:655196»
Al-Otaibi, JS.*; Mary, YS.; Mary, YS.; Krátký, M.; Vinšová, J.; Gamberini, MC.: Spectroscopic and SERS investigations of (E)-3-[(3-methoxybenzylidene)amino]rhodanine - Experimental, DFT and MD analyses in solvents. Journal of the Indian Chemical Society, 2024, 101 (8), art.101205. JCR: IF23:3.2(Q2) AIS23:0.220(Q3) WOS:001257774500001 EID:2-s2.0-85195217549 DOI:10.1016/j.jics.2024.101205 OBD:655685»
Al-Otaibi, JS.; Mary, YS.*; Mary, YS.; Krátký, M.; Vinšová, J.; Gamberini, MC.: Insights into the Adsorption Nature of a Bioactive Anticancer Derivative of Benzenesulfonate on Silver Colloids at Various Concentrations: Experimental and DFT Investigations. Polycyclic Aromatic Compounds, 2024, 44 (5), 3009—3021. JCR: IF23:2.4(Q2) AIS23:0.292(Q2) WOS:001015414400001 EID:2-s2.0-85162943190 DOI:10.1080/10406638.2023.2228449 OBD:639798»
Alva Gallegos, R.; Jirkovský, E.; Mladěnka, P.; Carazo, A.*: Small phenolic compounds as potential endocrine disruptors interacting with estrogen receptor alpha. Frontiers in Endocrinology, 2024, 15 (October), art.1440654. JCR: IF23:3.9(Q2) AIS23:1.192(Q2) DOI:10.3389/fendo.2024.1440654 OBD:654387»
Arndt, T.*: Farmaceutická firma Norgine v Ústí nad Labem (Aussig). Česká a slovenská farmacie, 2024, 73 (3), E23—E26. DOI:10.36290/csf.2024.034 OBD:655960»
Bakker, MJ.; Gaffour, A.; Juhás, M.; Zapletal, V.; Stošek, J.; Bratholm, LA.; Pavlíková Přecechtělová, J.*: Streamlining NMR Chemical Shift Predictions for Intrinsically Disordered Proteins: Design of Ensembles with Dimensionality Reduction and Clustering. Journal of Chemical Information and Modeling, 2024, 64 (16), 6542—6556. JCR: IF23:5.7(Q1Q1Q1Q2) AIS23:1.425(Q1Q1Q1Q1[Đ1]) WOS:001284734600001 EID:2-s2.0-85200534789 PMID:39099394 DOI:10.1021/acs.jcim.4c00809 OBD:655652»
Bednárik, Š.; Demuth, J.; Kernal, J.; Miletín, M.; Zimčík, P.; Nováková, V.*: Tuning Electron-Accepting Properties of Phthalocyanines for Charge Transfer Processes. Inorganic Chemistry, 2024, 63 (19), 8799—8806. JCR: IF23:4.3(Q1) AIS23:0.692(Q1) WOS:001226327400001 EID:2-s2.0-85192165758 PMID:38679903 DOI:10.1021/acs.inorgchem.4c00527 OBD:655672»
Bencsik, T.; Balázs, VL.; Farkas, Á.; Csikós, E.; Horváth, A.; Ács, K.; Kocsis, M.; Doseděl, M.; Bittner Fialová, S.; Czigle, S.; Nagy, M.; Tóth, J.; Protti, M.; Mercolini, L.; Mladěnka, P.; Szentpéteri, J.*; Horváth, G.: Herbal drugs in chronic venous disease treatment: An update. Fitoterapia, 2024, 179 (December), art.106256. JCR: IF23:2.5(Q3Q3) AIS23:0.433(Q3Q3) WOS:001346402300001 EID:2-s2.0-85206639201 PMID:39419127 DOI:10.1016/j.fitote.2024.106256 OBD:655855»
Blaha, V.; Urbánková Rathouská, J.; Langrová, H.; Bláha, M.; Studnička, J.; Andrýs, C.; Löfflerová, V.; Lánská, M.; Vejražková, E.; Nachtigal, P.*; Stěpanov, A.: Soluble endoglin as a biomarker of successful rheopheresis treatment in patients with age-related macular degeneration. Scientific Reports, 2024, 14 (1), art.28902. JCR: IF23:3.8(Q1) AIS23:1.061(Q1) EID:2-s2.0-85209711871 PMID:39572693 DOI:10.1038/s41598-024-80375-5 OBD:655681»
Bužančić, I.; Belec, D.; Držaić, M.; Kummer, I.; Brkić, J.; Fialová, D.; Ortner Hadžiabdić, M.*: Clinical decision-making in benzodiazepine deprescribing by healthcare providers vs. AI-assisted approach. British Journal of Clinical Pharmacology, 2024, 90 (3), 662—674. JCR: IF23:3.1(Q2) AIS23:1.111(Q1) WOS:001113011000001 EID:2-s2.0-85178459514 PMID:37949663 DOI:10.1111/bcp.15963 OBD:655278»
Bužančić, I.; Držaić, M.; Kummer, I.; Ortner Hadžiabdić, M.*; Brkić, J.; Fialová, D.: Deprescribing potential of commonly used medications among community-dwelling older adults: insights from a pharmacist's geriatric assessment. Scientific Reports, 2024, 14 (1), art.6235. JCR: IF23:3.8(Q1) AIS23:1.061(Q1) WOS:001185787000054 EID:2-s2.0-85187891254 PMID:38485992 DOI:10.1038/s41598-024-56780-1 OBD:655284»
Carazo, A.*; Hrubša, M.; Konečný, L.; Gunaseelan, C.; Fadraersada, J.; Skořepa, P.; Paclíková, M.; Musil, F.; Karlíčková, J.; Javorská, L.; Matoušová, K.; Kujovská Krčmová, L.; Šmahelová, A.; Blaha, V.; Mladěnka, P.: Correlations among different platelet aggregation pathways in a group of healthy volunteers. Platelets, 2024, 35 (1), art.2336093. JCR: IF23:2.5(Q3Q2) AIS23:0.873(Q3Q2) WOS:001201363700001 EID:2-s2.0-85190097539 PMID:38602464 DOI:10.1080/09537104.2024.2336093 OBD:654368»
Cífková, E.; Karahoda, R.; Stráník, J.; Abad, C.; Kacerovský, M.; Lísa, M.*; Štaud, F.*: Metabolomic analysis of the human placenta reveals perturbations in amino acids, purine metabolites, and small organic acids in spontaneous preterm birth. EXCLI Journal, 2024, 23 (February), 264—282. JCR: IF23:3.8(Q1) AIS23:0.720(Q2) WOS:001166548100001 EID:2-s2.0-85209391579 PMID:38487084 DOI:10.17179/excli2023-6785 OBD:647241»
Czyż, E.; Erben, J.; Vinter, J.; Švec, F.; Šatínský, D.*: Supported liquid phase extraction using wetted nanofiber discs as a simple approach for in-vial extraction of chlorophenols and insecticides from river water prior to HPLC-DAD analysis. Analytica Chimica Acta, 2024, 1327 (October), art.343137. JCR: IF23:5.7(Q1) AIS23:0.888(Q1) WOS:001306483300001 EID:2-s2.0-85202153540 PMID:39266060 DOI:10.1016/j.aca.2024.343137 OBD:651052»
Czyż, E.; Švec, F.; Šatínský, D.*: Recent advances in application of nanofibers as extraction sorbents in environmental analysis. Trends in Analytical Chemistry, 2024, 180 (November), art.117970. JCR: IF23:11.8(Q1) AIS23:2.045(Q1[Đ1]) WOS:001317522800001 EID:2-s2.0-85203826398 DOI:10.1016/j.trac.2024.117970 OBD:653513»
Demel, I.*; Skopal, D.; Šafránková, E.; Rozsívalová, P.; Jindra, P.; Šrámek, J.; Turková, A.; Vydra, J.; Labská, K.; Vedrová, J.; Čerňan, M.; Szotkowski, T.; Móciková, H.; Hynková, L.; Šušol, O.; Kováčová, I.; Belada, D.; Hájek, R.: Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study. Annals of Hematology, 2024, 103 (3), 981—992. JCR: IF23:3.0(Q2) AIS23:0.888(Q2) WOS:001125370600001 EID:2-s2.0-85179728882 PMID:38092996 DOI:10.1007/s00277-023-05572-0 OBD:640486»
Demuth, J.; Kaushik, R.; Kozlíková, M.; Rando, C.; Macháček, M.; Nováková, V.; Šindelář, V.*; Zimčík, P.*: BODIPY-cucurbituril complexes: supramolecular approach toward improvement of photodynamic activity. Materials Advances, 2024, 5 (9), 3915—3920. JCR: IF23:5.2(Q2) AIS23:0.861(Q2) WOS:001191333100001 EID:2-s2.0-85192979813 DOI:10.1039/d3ma01164j OBD:655201»
Dias, P.; Salam, R.; Moravcová, M.; Saadat, S.; Pourová, J.; Vopršalová, M.; Jirkovský, E.; Duintjer Tebbens, J.; Mladěnka, P.*: 3-methoxycatechol causes vasodilation likely via KV channels: ex vivo, in silico docking and in vivo study. Vascular Pharmacology, 2024, 156 (September), art.107418. JCR: IF23:3.5(Q2) AIS23:0.921(Q1) WOS:001302807400001 EID:2-s2.0-85201899406 PMID:39159736 DOI:10.1016/j.vph.2024.107418 OBD:654157»
Dias, P.; Salam, R.; Pourová, J.; Vopršalová, M.; Konečný, L.; Jirkovský, E.; Duintjer Tebbens, J.; Mladěnka, P.*: The quercetin metabolite 4-methylcatechol causes vasodilation via voltage-gated potassium (KV) channels. Food and Function, 2024, 15 (22), 11047—11059. JCR: IF23:5.1(Q1Q1) AIS23:0.841(Q2Q1) WOS:001338990200001 EID:2-s2.0-85206907903 PMID:39422021 DOI:10.1039/d3fo04672a OBD:654916»
Doležal, M.; Kastner, P.: Kontaminace léčiv nitrosaminy, staronový problém. Česká a slovenská farmacie, 2024, 73 (4), 228—232. DOI:10.36290/csf.2024.041 OBD:655870»
Domecký, P.; Rejman Patková, A.; Žaloudková, L.; Kučera, T.; Šponer, P.; Malý, J.*: Rethinking risk prediction: The role of albumin and other parameters in implant-associated complications after hip or knee arthroplasty. PLoS One, 2024, 19 (7), art.e0306468. JCR: IF23:2.9(Q1) AIS23:0.886(Q2) WOS:001282593200003 EID:2-s2.0-85199920707 PMID:39074134 DOI:10.1371/journal.pone.0306468 OBD:655041»
Doseděl, M.; Hajduchová, H.; Malá-Ládová, K.: Nevhodné zásahy do pevných lékových forem - kazuistiky. Ošetřovatelské perspektivy, 2024, 7 (1), 95—103. DOI:10.25142/osp.2024.003 OBD:655845»
Ďurinová, A.; Smutná, L.*; Bárta, P.; Kamaraj, R.; Smutný, T.; Schmierer, B.; Pávek, P.; Trejtnar, F.: Radiolabeled 15-mer peptide internalization is mediated by megalin (LRP2 receptor) in a CRISPR/Cas9-based LRP2 knockout human kidney cell model. EJNMMI Radiopharmacy and Chemistry, 2024, 9 (1), art.32. JCR: IF23:4.4(Q1Q2Q1) AIS23:1.053(Q1Q1Q1[Đ1]) WOS:001205507100001 EID:2-s2.0-85190689099 PMID:38637347 DOI:10.1186/s41181-024-00262-2 OBD:655806»
Dvořáčková, S.; Malá-Ládová, K.; Mertová, T.; Kolmanová, E.; Malý, J.*: Přímá perorální antikoagulancia pohledem českých farmaceutů - názory, postoje, sebejistota a edukace pacientů při výdeji v lékárně. Česká a slovenská farmacie, 2024, 73 (1), 22—26. DOI:10.36290/csf.2024.004 OBD:655958»
Dwivedi, A.; Mazumder, A.; Pullmannová, P.; Paraskevopoulou, A.; Opálka, L.; Kováčik, A.; Macháček, M.; Jančálková, P.; Svačinová, P.; Peterlik, H.; Maixner, J.; Vávrová, K.*: Lipid Monolayer on Cell Surface Protein Templates Functional Extracellular Lipid Assembly. Small, 2024, 20 (26), art.2307793. JCR: IF23:13.0(Q1Q1Q1Q1Q1Q1) AIS23:2.626(Q1Q1Q1Q1Q1Q1[Đ1]) WOS:001145467600001 EID:2-s2.0-85182634307 PMID:38243890 DOI:10.1002/smll.202307793 OBD:654814»
Eissazadeh, S.; Mohammadi, SN.; Alaei Faradonbeh, F.; Urbánková Rathouská, J.; Němečková, I.; Tripská, K.; Vitverová, B.; Dohnálková, E.; Vašinová, M.; Fikrová, P.; Igreja e Sá, IC.; Mičuda, S.; Nachtigal, P.*: Endoglin and soluble endoglin in liver sinusoidal endothelial dysfunction in vivo. Biochimica et Biophysica Acta - Molecular Basis of Disease, 2024, 1870 (3), art.166990. JCR: IF23:4.2(Q2Q1) AIS23:1.273(Q2Q1) WOS:001143898300001 EID:2-s2.0-85180599220 PMID:38110128 DOI:10.1016/j.bbadis.2023.166990 OBD:641045»
Fadraersada, J.; Alva Gallegos, R.; Skořepa, P.; Musil, F.; Javorská, L.; Matoušová, K.; Kujovská Krčmová, L.; Paclíková, M.; Carazo, A.; Blaha, V.; Mladěnka, P.*: Head-to-head ex vivo comparison of clinically used direct anticoagulant drugs. Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 (6), 4461—4470. JCR: IF23:3.1(Q2) AIS23:0.534(Q3) WOS:001127348700001 EID:2-s2.0-85180191308 PMID:38112731 DOI:10.1007/s00210-023-02891-x OBD:654366»
Fialová, D.; Topinková, E.; Jurašková, B.; Matějková, A.; Antonenko, O.; Sulková-Dusilová, S.: Interdisciplinární spolupráce klinických farmaceutů, praktických lékařů a geriatrů v individualizované farmakoterapii ve stáří - novinky v oblasti vzdělávání, výzkumu a klinické praxe. Practicus, 2024, 23 (7), 17—23. OBD:654525»
Gazárková, T.; Kočová Vlčková, H.; Plachká, K.; Vagnerová, K.; Dubecová, D.; Klusoňová, P.; Pácha, J.; Švec, F.; Nováková, L.*: Comprehensive targeted profiling of multiple steroid classes in rodent plasma using liquid chromatography-mass spectrometry. Analytica Chimica Acta, 2024, 1332 (December), art.343362. JCR: IF23:5.7(Q1) AIS23:0.888(Q1) WOS:001348406900001 EID:2-s2.0-85207322017 DOI:10.1016/j.aca.2024.343362 OBD:655747»
Hajduchová, H.; Červený, M.; Brabcová, I.; Chloubová, I.; Prokešová, R.; Malý, J.; Doseděl, M.; Tesař, O.; Vlček, J.; Tóthová, V.*: Medication administration errors in the selected Czech hospitals: An observational study. Pielegniarstwo XXI wieku, 2024, 23 (1), 36—40. JCR: IF23:0.2(Q4) AIS23:—(—) WOS:001199145100001 EID:2-s2.0-85190811865 DOI:10.2478/pielxxiw-2024-0009 OBD:655719»
Háková, M.; Modebelu, U.; Erben, J.; Matysová, L.; Šatínský, D.; Švec, F.; Sklenářová, H.*: Comparative study of drug release from electrospun nanofibers loaded with clotrimazole via two different approaches using a fully automated sequential injection system. Talanta, 2024, 269 (March), art.125415. JCR: IF23:5.6(Q1) AIS23:0.765(Q1) WOS:001165955300001 EID:2-s2.0-85178021706 PMID:38006728 DOI:10.1016/j.talanta.2023.125415 OBD:654493»
Horváth, L.; Biri-Kovács, B.; Baranyai, Z.; Stipsicz, B.; Méhes, E.; Jezsó, B.; Krátký, M.; Vinšová, J.; Bősze, S.*: New Salicylanilide Derivatives and Their Peptide Conjugates as Anticancer Compounds: Synthesis, Characterization, and In Vitro Effect on Glioblastoma. ACS Omega, 2024, 9 (15), 16927—16948. JCR: IF23:3.7(Q2) AIS23:0.639(Q2) WOS:001200641000001 EID:2-s2.0-85190608733 PMID:38645331 DOI:10.1021/acsomega.3c05727 OBD:655702»
Chmelařová, H.; Catapano, MC.; Garrigues, J.*; Švec, F.; Nováková, L.*: Advancing drug safety and mitigating health concerns: High-resolution mass spectrometry in the levothyroxine case study. JOURNAL OF PHARMACEUTICAL ANALYSIS, 2024, 14 (9), art.100970. JCR: IF23:6.1(Q1) AIS23:1.131(Q1) WOS:001321063600001 EID:2-s2.0-85204372504 PMID:39350965 DOI:10.1016/j.jpha.2024.100970 OBD:655746»
Jadeja, S.; Karsakov, A.; Sklenářová, H.; Lenčo, J.*: Evaluating C18 stationary phases with a positively charged surface for proteomic LC-MS applications using mobile phase acidified with reduced formic acid concentration. Journal of Chromatography A, 2024, 1730 (August), art.465142. JCR: IF23:3.8(Q1Q1) AIS23:0.512(Q3Q2) WOS:001271294900001 EID:2-s2.0-85198279627 PMID:39002507 DOI:10.1016/j.chroma.2024.465142 OBD:654194»
Juhásová, Z.; Maříková, M.; Vlček, J.: Polékové hospitalizace - zkušenosti z České republiky. Česká a slovenská farmacie, 2024, 73 (2), 93—102. DOI:10.36290/csf.2024.015 OBD:655718»
Kamaraj, R.; Ghosh, S.; Das, S.; Sen, S.; Kumar, P.; Majumdar, M.; Dasgupta, R.; Mukherjee, S.; Das, S.; Ghose, I.; Pávek, P.; Raja Karuppiah, MP.; Chuturgoon, AA.; Anand, K.: Targeted Protein Degradation (TPD) for Immunotherapy: Understanding Proteolysis Targeting Chimera-Driven Ubiquitin-Proteasome Interactions. Bioconjugate Chemistry, 2024, 35 (8), 1089—1115. JCR: IF23:4.0(Q1Q2Q2Q1) AIS23:0.900(Q2Q2Q2Q1[Đ1]) WOS:001279939400001 EID:2-s2.0-85198577941 PMID:38990186 DOI:10.1021/acs.bioconjchem.4c00253 OBD:651112»
Karabanovich, G.; Fabiánová, V.; Vocat, A.; Dušek, J.; Valášková, L.; Stolaříková, J.; Kitson, RRA.; Pávek, P.; Vávrová, K.; Djaout, K.; Mikušová, K.; Baulard, AR.; Cole, ST.; Korduláková, J.; Roh, J.*: Both Nitro Groups Are Essential for High Antitubercular Activity of 3,5-Dinitrobenzylsulfanyl Tetrazoles and 1,3,4-Oxadiazoles through the Deazaflavin-Dependent Nitroreductase Activation Pathway. Journal of Medicinal Chemistry, 2024, 67 (1), 81—109. JCR: IF23:6.9(Q1) AIS23:1.652(Q1[Đ1]) EID:2-s2.0-85181571509 PMID:38157261 DOI:10.1021/acs.jmedchem.3c00925 OBD:640453»
Karahoda, R.; Váchalová, V.; Portillo, R.; Mahrla, F.; Viňas-Noguera, M.; Abad, C.; Štaud, F.*: Developmental expression of catecholamine system in the human placenta and rat fetoplacental unit. Scientific Reports, 2024, 14 (1), art.6948. JCR: IF23:3.8(Q1) AIS23:1.061(Q1) WOS:001190086900011 EID:2-s2.0-85188441838 PMID:38521816 DOI:10.1038/s41598-024-57481-5 OBD:655759»
Khalikova, M.; Jireš, J.; Horáček, O.; Douša, M.; Kučera, R.; Nováková, L.*: What is the role of current mass spectrometry in pharmaceutical analysis? Mass Spectrometry Reviews, 2024, 43 (3), 560—609. JCR: IF23:6.9(Q1) AIS23:1.868(Q1[Đ1]) WOS:001037413700001 EID:2-s2.0-85165913551 PMID:37503656 DOI:10.1002/mas.21858 OBD:655744»
Kholová, A.; Lhotská, I.; Erben, J.; Chvojka, J.; Švec, F.; Solich, P.; Šatínský, D.*: Advanced nanofibrous sorbents for the extraction of pollutants from river water and protein-containing matrices. Talanta, 2024, 269 (March), art.125449. JCR: IF23:5.6(Q1) AIS23:0.765(Q1) WOS:001128245500001 EID:2-s2.0-85178656357 PMID:38039679 DOI:10.1016/j.talanta.2023.125449 OBD:655646»
Kitson, RRA.*; Kitsonová, D.; Siegel, D.; Ross, D.; Moody, ChJ.*: Geldanamycin, a Naturally Occurring Inhibitor of Hsp90 and a Lead Compound for Medicinal Chemistry. Journal of Medicinal Chemistry, 2024, 67 (20), 17946—17963. JCR: IF23:6.9(Q1) AIS23:1.652(Q1[Đ1]) WOS:001328673900001 EID:2-s2.0-85206186856 PMID:39361055 DOI:10.1021/acs.jmedchem.4c01048 OBD:655480»
Kolmanová, E.*; Tesař, O.: Dostupné diagnostické testy v lékárně a role farmaceuta. Česká a slovenská farmacie, 2024, 73 (3), 193—198. DOI:10.36290/csf.2024.030 OBD:655959»
Konečný, L.; Hrubša, M.; Karlíčková, J.; Carazo, A.; Javorská, L.; Matoušová, K.; Kujovská Krčmová, L.; Blaha, V.; Bláha, M.; Mladěnka, P.*: The Impact of Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies with and without Apheresis on Platelet Aggregation in Familial Hypercholesterolemia. Cardiovascular Drugs and Therapy, 2024, 38 (5), 959—970. JCR: IF23:3.1(Q2Q2) AIS23:0.824(Q2Q2) WOS:000980357300001 EID:2-s2.0-85156105870 PMID:37129685 DOI:10.1007/s10557-023-07455-y OBD:654156»
Kooijmans, ECM.*; Hoogendijk, EO.; Pokladníková, J.; Smalbil, L.; Szczerbińska, K.; Barańska, I.; Ziuziakowska, A.; Fialová, D.; Onder, G.; Declercq, A.; Finne-Soveri, H.; Hoogendoorn, M.; van Hout, HPJ.; Joling, KJ.: The prevalence of non-pharmacological interventions in older homecare recipients: an overview from six European countries. European Geriatric Medicine, 2024, 15 (1), 243—252. JCR: IF23:3.5(Q2) AIS23:0.870(Q3) WOS:001078336700002 EID:2-s2.0-85173546156 PMID:37792242 DOI:10.1007/s41999-023-00868-w OBD:639850»
Krátký, M.*: Novel sulfonamide derivatives as a tool to combat methicillin-resistant Staphylococcus aureus. Future Medicinal Chemistry, 2024, 16 (6), 545—562. JCR: IF23:3.2(Q3) AIS23:0.665(Q2) WOS:001161453200001 EID:2-s2.0-85186266149 PMID:38348480 DOI:10.4155/fmc-2023-0116 OBD:644334»
Krátký, M.*; Houngbedji, N.; Vinšová, J.: Hidden potential of hydrazinecarboxamides (semicarbazides) as potential antimicrobial agents: A review. Biomedicine & Pharmacotherapy, 2024, 180 (November), art.117556. JCR: IF23:6.9(Q1Q1) AIS23:1.141(Q2Q1) EID:2-s2.0-85206151882 PMID:39405901 DOI:10.1016/j.biopha.2024.117556 OBD:653847»
Krátký, M.*; Houngbedji, N.; Vinšová, J.: Hydrazinecarboxamides: Comprehensive review of their anticancer, anticonvulsive, anti-inflammatory, enzyme inhibition, antioxidant and other activities. European Journal of Medicinal Chemistry, 2024, 279 (December), art.116835. JCR: IF23:6.0(Q1) AIS23:0.979(Q1) WOS:001315731600001 EID:2-s2.0-85203468111 PMID:39270449 DOI:10.1016/j.ejmech.2024.116835 OBD:655686»
Krátký, M.*; Nováčková, K.; Svrčková, K.; Švarcová, M.; Štěpánková, Š.: New 3-amino-2-thioxothiazolidin-4-one-based inhibitors of acetyl- and butyryl-cholinesterase: synthesis and activity. Future Medicinal Chemistry, 2024, 16 (1), 59—74. JCR: IF23:3.2(Q3) AIS23:0.665(Q2) WOS:001112538400001 EID:2-s2.0-85182597816 PMID:38047370 DOI:10.4155/fmc-2023-0268 OBD:655683»
Křoustková, J.*; Kohelová, E.; Muthná, D.; Kuneš, J.; Havelek, R.; Vrabec, R.; Malaník, M.; Suchánková, D.; Chlebek, J.; Jenčo, J.; Kosturko, Š.; Cahlíková, L.: Undescribed Amaryllidaceae Alkaloids from Zephyranthes citrina and Their Cytotoxicity. Journal of Natural Products, 2024, 87 (9), 2317—2326. JCR: IF23:3.4(Q2Q2Q1) AIS23:0.709(Q2Q2Q1) WOS:001306492900001 EID:2-s2.0-85203367789 PMID:39229678 DOI:10.1021/acs.jnatprod.4c00825 OBD:655079»
Kujovská Krčmová, L.*; Javorská, L.; Matoušová, K.; Šmahel, P.; Skála, M.; Kopecký, M.; Suwanvecho, Ch.; Přívratská, N.; Turoňová, D.; Melichar, B.: Evaluation of inflammatory biomarkers and vitamins in hospitalized patients with SARS-CoV-2 infection and post-COVID syndrome. Clinical Chemistry and Laboratory Medicine, 2024, 62 (6), 1217—1227. JCR: IF23:3.8(Q1) AIS23:0.882(Q1) WOS:001165608700001 EID:2-s2.0-85185811231 PMID:38374668 DOI:10.1515/cclm-2023-1297 OBD:648831»
Kukla, R.; Nouzovská, K.; Ryšková, L.; Rozsívalová, P.; Pavlik, I.; Boštík, P.*: Successful treatment of Keratitis caused by Mycobacterium chelonae and an overview of previous cases in Europe. Annals of Clinical Microbiology and Antimicrobials, 2024, 23 (1), art.92. JCR: IF23:4.6(Q1) AIS23:1.240(Q1) WOS:001337148300001 EID:2-s2.0-85205978104 PMID:39385246 DOI:10.1186/s12941-024-00752-w OBD:654639»
Kummer, I.; Reissigová, J.; Lukačišinová, A.; Ortner Hadžiabdić, M.; Štuhec, M.; Liperoti, R.; Finne-Soveri, H.; Onder, G.; van Hout, H.; Fialová, D.: Polypharmacy and potentially inappropriate prescribing of benzodiazepines in older nursing home residents. Annals of Medicine, 2024, 56 (1), art.2357232. JCR: IF23:4.9(Q1) AIS23:1.324(Q1) WOS:001238445200001 EID:2-s2.0-85195251377 PMID:38833339 DOI:10.1080/07853890.2024.2357232 OBD:655321»
Lhotská, I.*; Háková, M.; Erben, J.; Chvojka, J.; Švec, F.; Šatínský, D.: Stirred discs from polycaprolactone nanofibers highly doped with graphene for straightforward preconcentration of pollutants in environmental waters. Talanta, 2024, 266 (January), art.124975. JCR: IF23:5.6(Q1) AIS23:0.765(Q1) WOS:001058377900001 EID:2-s2.0-85165354249 PMID:37487271 DOI:10.1016/j.talanta.2023.124975 OBD:654187»
Lhotská, I.*; Kholová, A.; Švec, F.; Šatínský, D.: Nanofibers prepared from synthetic polymers and biopolymers as advanced extraction materials for sample preparation prior to liquid chromatography. Trends in Analytical Chemistry, 2024, 180 (November), art.117912. JCR: IF23:11.8(Q1) AIS23:2.045(Q1[Đ1]) WOS:001301548600001 EID:2-s2.0-85201700523 DOI:10.1016/j.trac.2024.117912 OBD:650771»
Lukačišinová, A.*; Reissigová, J.; Ortner-Hadžiabdić, M.; Brkić, J.; Okuyan, B.; Volmer, D.; Tadić, I.; Modamio, P.; Marino, EL.; Tachkov, K.; Liperotti, R.; Onder, G.; Finne-Soveri, H.; van Hout, H.; Howard, EP.; Fialová, D.: Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries. BMC Geriatrics, 2024, 24 (1), art.240. JCR: IF23:3.4(Q2Q2) AIS23:1.103(Q2Q1) WOS:001180560000003 EID:2-s2.0-85187196137 PMID:38454372 DOI:10.1186/s12877-024-04742-7 OBD:655282»
Mandrioli, R.; Cirrincione, M.; Saladini, B.; Girotti, S.; Mladěnka, P.; Protti, M.*; Mercolini, L.: Development of an accelerated ageing protocol for the study of phytocannabinoid stability in Cannabis sativa L. Journal of Pharmaceutical and Biomedical Analysis, 2024, 251 (December), art.116422. JCR: IF23:3.1(Q2Q2) AIS23:0.500(Q2Q3) WOS:001303030700001 EID:2-s2.0-85202194201 PMID:39197204 DOI:10.1016/j.jpba.2024.116422 OBD:654155»
Maseko, TE.; Elkalaf, M.; Peterová, E.; Lotková, H.; Staňková, P.; Melek, J.; Dušek, J.; Žádníková, P.; Čížková, D.; Bezrouk, A.; Pávek, P.; Červinková, Z.; Kučera, O.*: Comparison of HepaRG and HepG2 cell lines to model mitochondrial respiratory adaptations in non-alcoholic fatty liver disease. International Journal of Molecular Medicine, 2024, 53 (2), art.18. JCR: IF23:5.7(Q1) AIS23:0.856(Q2) WOS:001140754700001 EID:2-s2.0-85182027146 PMID:38186319 DOI:10.3892/ijmm.2023.5342 OBD:646114»
Mermer, K.*; Jas, E.; Paluch, J.; Woźniakiewicz, A.; Woźniakiewicz, M.; Miśkowiec, P.; Chocholouš, P.; Sklenářová, H.; Kozak, J.: Flow analysis-solid phase extraction system and UHPLC-MS/MS analytical methodology for the determination of antiviral drugs in surface water. Environmental Science and Pollution Research, 2024, 31 (37), 49546—49559. JCR: IF23:—(—) AIS23:0.726(Q2) EID:2-s2.0-85200030873 PMID:39080168 DOI:10.1007/s11356-024-34466-5 OBD:655199»
Mrštná, K.; Matoušová, K.; Kujovská Krčmová, L.*; Carazo, A.; Pourová, J.; Mladěnka, P.; Matysová, L.; Švec, F.: Analysis of vitamin K1 and major K2 variants in rat/human serum and lipoprotein fractions by a rapid simple, and sensitive UHPLC-MS/MS methods. Journal of Chromatography A, 2024, 1714 (January), art.464548. JCR: IF23:3.8(Q1Q1) AIS23:0.512(Q3Q2) WOS:001134754400001 EID:2-s2.0-85178139487 PMID:38043166 DOI:10.1016/j.chroma.2023.464548 OBD:643847»
Mrštná, K.; Turoňová, D.; Suwanvecho, Ch.; Švec, F.; Kujovská Krčmová, L.*: The power of modern extraction techniques: A breakthrough in vitamin K extraction from human serum. Microchemical Journal, 2024, 198 (March), art.110170. JCR: IF23:4.9(Q1) AIS23:0.619(Q2) WOS:001203047400001 EID:2-s2.0-85187300798 DOI:10.1016/j.microc.2024.110170 OBD:649375»
Nálevková, K.; Hendrychová, T.; Koblížek, V.; Sedlák, V.; Malý, J.*: Efektivní intervence ke zvýšení adherence k inhalační terapii pacientů s bronchiálním astmatem. Klinická farmakologie a farmacie, 2024, 38 (1), 31—37. EID:2-s2.0-85191520236 DOI:10.36290/far.2024.005 OBD:647922»
Nawrot, D.*; Ambrożkiewicz-Mosler, W.; Doležal, M.; Bouz, G.*: Antistaphylococcal discovery pipeline; where are we now? European Journal of Medicinal Chemistry, 2024, 266 (February), art.116077. JCR: IF23:6.0(Q1) AIS23:0.979(Q1) WOS:001166226000001 EID:2-s2.0-85182552899 PMID:38219657 DOI:10.1016/j.ejmech.2023.116077 OBD:654817»
Němečková, I.; Eissazadeh, S.; Urbánková Rathouská, J.; Šilhavý, J.; Malínská, H.; Pravenec, M.; Nachtigal, P.*: Transgenic human C-reactive protein affects oxidative stress but not inflammation biomarkers in the aorta of spontaneously hypertensive rats. BMC Cardiovascular Disorders, 2024, 24 (1), art.211. JCR: IF23:2.0(Q3) AIS23:0.592(Q3) WOS:001204537400004 EID:2-s2.0-85190712365 PMID:38627621 DOI:10.1186/s12872-024-03870-7 OBD:654851»
Nencka, R.; Mejdrová, I.; Pávek, P.; Dušek, J.: Selective Ligands of Human Constitutive Androstane Receptor. Munich: European Patent Office, 2024. Patent № EP3962915. OBD:654414»
Novotný, J.*; Svobodová, Z.*; Ilićová, M.; Hrušková, D.; Košťálová, J.; Bílková, Z.; Foret, F.: Advantages of stereolithographic 3D printing in the fabrication of the Affiblot device for dot-blot assays. Microchimica Acta, 2024, 191 (8), art.442. JCR: IF23:5.4(Q1) AIS23:0.708(Q1) WOS:001261438400005 EID:2-s2.0-85197471223 PMID:38954238 DOI:10.1007/s00604-024-06512-z OBD:655805»
Očovská, Z.; Procházková, J.; Maříková, M.; Vlček, J.*: Renal drug dosage adjustments and adverse drug events in patients with chronic kidney disease admitted to the hospital: a cross-sectional study. Expert Opinion on Drug Safety, 2024, 23 (4), 457—467. JCR: IF23:3.0(Q2) AIS23:0.962(Q1) WOS:001159881100001 EID:2-s2.0-85184926453 PMID:38332533 DOI:10.1080/14740338.2023.2295980 OBD:649930»
Ogadah, ChU.; Mrštná, K.; Matysová, L.; Müllertz, A.; Rades, T.; Niederquell, A.; Šklubalová, Z.; Vraníková, B.*: Comparison of the liquisolid technique and co-milling for loading of a poorly soluble drug in inorganic porous excipients. International Journal of Pharmaceutics, 2024, 650 (January), art.123702. JCR: IF23:5.3(Q1) AIS23:0.748(Q2) WOS:001139002000001 EID:2-s2.0-85181845443 PMID:38086492 DOI:10.1016/j.ijpharm.2023.123702 OBD:643850»
Palano, S.; Turoňová, D.; Protti, M.; Kujovská Krčmová, L.; Sardella, R.; Mladěnka, P.; Mandrioli, R.; Girotti, S.; Mercolini, L.*: Next generation microsampling towards sustainable forensic analysis: Volumetric DBS for cocaine and metabolites. Microchemical Journal, 2024, 203 (August), art.110937. JCR: IF23:4.9(Q1) AIS23:0.619(Q2) WOS:001332692500001 EID:2-s2.0-85195372758 DOI:10.1016/j.microc.2024.110937 OBD:649637»
Pallabothula, VSK.*; Abdalrahman, NT.; Mori, M.; Fekri, AH.; Janďourek, O.; Konečná, K.; Paterová, P.; Novák, M.; Dudášová-Hatoková, P.; Štěrbová-Kovaříková, P.; Castellano, C.; Meneghetti, F.; Villa, S.; Kuneš, J.; Juhás, M.; Zitko, J.*: A hit expansion of 3-benzamidopyrazine-2-carboxamide: Toward inhibitors of prolyl-tRNA synthetase with antimycobacterial activity. Archiv der Pharmazie, 2024, 357 (8), art.e2400171. JCR: IF23:4.3(Q2Q2Q1) AIS23:0.561(Q3Q2Q3) WOS:001214414200001 EID:2-s2.0-85192246980 PMID:38710636 DOI:10.1002/ardp.202400171 OBD:648076»
Paraskevopoulos, G.; Fandrei, F.; Pratihast, AK.; Paraskevopoulou, A.; Panoutsopoulou, E.; Opálka, L.; Mithu, VS.; Huster, D.; Vávrová, K.*: Effects of imidazolium ionic liquids on skin barrier lipids - Perspectives for drug delivery. Journal of Colloid and Interface Science, 2024, 659 (April), 449—462. JCR: IF23:9.4(Q1) AIS23:1.235(Q2) WOS:001154614100001 EID:2-s2.0-85182890369 PMID:38183811 DOI:10.1016/j.jcis.2023.12.139 OBD:647769»
Paudyal, V.*; Okuyan, B.; Henman, MCh.; Stewart, D.; Fialová, D.; Hazen, A.; Lutters, M.; Oleárová, A.; Weidmann, AE.; Wirth, F.; Cadogan, CA.; Nazar, Z.: Scope, content and quality of clinical pharmacy practice guidelines: a systematic review. International Journal of Clinical Pharmacy, 2024, 46 (1), 56—69. JCR: IF23:2.6(Q2) AIS23:0.584(Q3) WOS:001106656100002 EID:2-s2.0-85177547171 PMID:37991663 DOI:10.1007/s11096-023-01658-x OBD:640927»
Phondeth, L.; Kamaraj, R.; Nilles, J.; Weiss, J.; Haefeli, WE.; Pávek, P.; Theile, D.*: Rifabutin but not rifampicin can partly out-balance P-glycoprotein induction by concurrent P-glycoprotein inhibition through high affinity binding to the inhibitory site. Archives of Toxicology, 2024, 98 (1), 223—231. JCR: IF23:4.8(Q1) AIS23:1.105(Q1) WOS:001083590000001 EID:2-s2.0-85174066552 PMID:37833491 DOI:10.1007/s00204-023-03618-w OBD:648565»
Pidaný, F.; Křoustková, J.; Jenčo, J.; Hradiská Breiterová, K.; Múčková, Ľ.; Nováková, L.; Kuneš, J.; Fibigar, J.; Kučera, T.; Novák, M.; Šorf, A.; Hrabinová, M.; Pulkrábková, L.; Janoušek, J.; Soukup, O.; Jun, D.; Korábečný, J.*; Cahlíková, L.*: Carltonine-derived compounds for targeted butyrylcholinesterase inhibition. RSC Medicinal Chemistry, 2024, 15 (5), 1601—1625. JCR: IF23:4.1(Q2Q2) AIS23:0.896(Q2Q2) WOS:001198194600001 EID:2-s2.0-85189808184 PMID:38784455 DOI:10.1039/d4md00060a OBD:654580»
Pilařová, V.; Plachká, K.; Herbsová, D.; Kosturko, Š.; Švec, F.; Nováková, L.*: Comprehensive two-step supercritical fluid extraction for green isolation of volatiles and phenolic compounds from plant material. Green Chemistry, 2024, 26 (11), 6480—6489. JCR: IF23:9.3(Q1Q1) AIS23:1.684(Q1Q1) WOS:001209557300001 EID:2-s2.0-85191863402 DOI:10.1039/d4gc00371c OBD:655318»
Pilařová, V.; Plachká, K.; Švec, F.; Nováková, L.*: Matrix effects in ultra-high performance supercritical fluid chromatography-mass spectrometry analysis of vitamin E in plasma: The effect of sample preparation and data processing. Talanta, 2024, 280 (December), art.126658. JCR: IF23:5.6(Q1) AIS23:0.765(Q1) WOS:001295120100001 EID:2-s2.0-85200975797 PMID:39137659 DOI:10.1016/j.talanta.2024.126658 OBD:655327»
Pilařová, V.; Socas-Rodríguez, B.; Nováková, L.; Essén, S.; Holm, C.; Turner, Ch.; Sandahl, M.*: Analysis of vitamin D and its metabolites in biological samples - Part I: Optimization and comparison of UHPSFC-MS/MS and UHPLC-MS/ MS methods. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2024, 1237 (April), art.124087. JCR: IF23:2.8(Q2Q2) AIS23:0.481(Q3Q2) WOS:001218418800001 EID:2-s2.0-85188436484 PMID:38513431 DOI:10.1016/j.jchromb.2024.124087 OBD:655329»
Pilařová, V.; Socas-Rodríguez, B.; Nováková, L.; Holm, C.; Sandahl, M.; Turner, Ch.*: Analysis of vitamin D and its metabolites in biological samples - Part II: Optimization of a sample preparation method for liver tissue. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2024, 1237 (April), art.124088. JCR: IF23:2.8(Q2Q2) AIS23:0.481(Q3Q2) WOS:001216254600001 EID:2-s2.0-85188655388 PMID:38520897 DOI:10.1016/j.jchromb.2024.124088 OBD:655330»
Plachká, K.; Pilařová, V.; Gazárková, T.; Švec, F.; Garrigues, JCh.; Nováková, L.*: Advancing Fundamental Understanding of Retention Interactions in Supercritical Fluid Chromatography Using Artificial Neural Networks: Polar Stationary Phases with -OH Moieties. Analytical Chemistry, 2024, 96 (31), 12748—12759. JCR: IF23:6.8(Q1) AIS23:1.224(Q1[Đ1]) WOS:001280432800001 EID:2-s2.0-85199785989 PMID:39069659 DOI:10.1021/acs.analchem.4c01811 OBD:650419»
Plachká, K.; Pilařová, V.; Kosturko, Š.; Škop, J.; Švec, F.; Nováková, L.*: Ultrahigh-Performance Supercritical Fluid Chromatography-Multimodal Ionization-Tandem Mass Spectrometry as a Universal Tool for the Analysis of Small Molecules in Complex Plant Extracts. Analytical Chemistry, 2024, 96 (7), 2840—2848. JCR: IF23:6.8(Q1) AIS23:1.224(Q1[Đ1]) WOS:001158975000001 EID:2-s2.0-85184809585 PMID:38300751 DOI:10.1021/acs.analchem.3c03599 OBD:655316»
Portillo, R.; Abad, C.; Synova, T.; Kastner, P.; Heblík, D.; Kučera, R.; Karahoda, R.; Štaud, F.*: Cannabidiol disrupts tryptophan metabolism in the human term placenta. Toxicology, 2024, 505 (June), art.153813. JCR: IF23:4.8(Q1Q1) AIS23:0.857(Q2Q1) WOS:001235229500001 EID:2-s2.0-85191354984 PMID:38663822 DOI:10.1016/j.tox.2024.153813 OBD:655761»
Rashidian, A.; Dušek, J.; Drastík, M.; Smutná, L.; Fritsche, K.; Braeuning, A.; Pijnenburg, D.; van Beuningen, R.; Honkakoski, P.; Poso, A.; Kronenberger, T.*; Pávek, P.*: Filling the Blank Space: Branched 4-Nonylphenol Isomers Are Responsible for Robust Constitutive Androstane Receptor (CAR) Activation by Nonylphenol. Environmental Science and Technology, 2024, 58 (16), 6913—6923. JCR: IF23:10.9(Q1Q1) AIS23:2.463(Q1Q1[Đ1]) WOS:001199628900001 EID:2-s2.0-85190141326 PMID:38593436 DOI:10.1021/acs.est.3c10096 OBD:646906»
Rassu, G.; Kočová Vlčková, H.; Giunchedi, P.; Dias, P.; Cossu, M.; Pourová, J.; Harčárová, P.; Lomozová, Z.; Nováková, L.; Gavini, E.*; Mladěnka, P.*: A water-soluble preparation for intravenous administration of isorhamnetin and its pharmacokinetics in rats. Chemico-Biological Interactions, 2024, 396 (June), art.111064. JCR: IF23:4.7(Q1Q1Q1) AIS23:0.775(Q2Q2Q2) WOS:001245090200001 EID:2-s2.0-85193491484 PMID:38768772 DOI:10.1016/j.cbi.2024.111064 OBD:654154»
Raza, MA.*; Aziz, S.; Iftikhar, D.; Anjum, I.; Fialová, D.: Addressing quality medication use among migrant patients: Establishment of an organization to provide culturally competent medication care. Saudi Pharmaceutical Journal, 2024, 32 (3), art.101922. JCR: IF23:3.0(Q2) AIS23:0.574(Q3) WOS:001175062500001 EID:2-s2.0-85183499906 PMID:38318317 DOI:10.1016/j.jsps.2023.101922 OBD:655280»
Ruzicka, J(.; Chocholouš, P.*: Next generation of flow analysis is based on flow programming. Talanta, 2024, 269 (March), art.125410. JCR: IF23:5.6(Q1) AIS23:0.765(Q1) WOS:001127734900001 EID:2-s2.0-85178378395 PMID:38035454 DOI:10.1016/j.talanta.2023.125410 OBD:654245»
Rychlá, N.; Navrátilová, M.; Kohoutová, E.; Raisová Stuchlíková, L.; Štěrbová, K.; Krátký, J.; Matoušková, P.; Szotáková, B.; Skálová, L.*: Flubendazole carbonyl reduction in drug-susceptible and drug-resistant strains of the parasitic nematode Haemonchus contortus: changes during the life cycle and possible inhibition. Veterinary Research, 2024, 55 (1), art.7. JCR: IF23:3.7(Q1) AIS23:0.787(Q1[Đ1]) WOS:001143862100003 EID:2-s2.0-85182541211 PMID:38225645 DOI:10.1186/s13567-023-01264-9 OBD:652035»
Smutný, T.*; Smutná, L.; Lochman, L.; Kamaraj, R.; Kučera, R.; Pávek, P.: Rifampicin and its derivatives: stability, disposition, and affinity towards pregnane X receptor employing 2D and 3D primary human hepatocytes. Biochemical Pharmacology, 2024, 229 (November), art.116500. JCR: IF23:5.3(Q1) AIS23:1.111(Q1) WOS:001302787100001 EID:2-s2.0-85201921952 PMID:39179119 DOI:10.1016/j.bcp.2024.116500 OBD:655385»
Starovoit, MR.; Jadeja, S.; Gazárková, T.; Lenčo, J.*: Mitigating In-Column Artificial Modifications in High-Temperature LC-MS for Bottom-Up Proteomics and Quality Control of Protein Biopharmaceuticals. Analytical Chemistry, 2024, 96 (36), 14531—14540. JCR: IF23:6.8(Q1) AIS23:1.224(Q1[Đ1]) WOS:001300790300001 EID:2-s2.0-85202749939 PMID:39196537 DOI:10.1021/acs.analchem.4c02819 OBD:655801»
Suwanvecho, Ch.; Kujovská Krčmová, L.*; Švec, F.: Centrifugal-assisted sample preparation techniques: Innovations and applications in bioanalysis. Trends in Analytical Chemistry, 2024, 180 (November), art.117909. JCR: IF23:11.8(Q1) AIS23:2.045(Q1[Đ1]) WOS:001297971300001 EID:2-s2.0-85201460259 DOI:10.1016/j.trac.2024.117909 OBD:653406»
Svobodová, G.; Šadibolová, M.; Velecká, E.; Mráziková, L.; Vaculová, P.; Matoušková, P.; Kuneš, J.; Maletínská, L.; Boušová, I.*: Metabolic Dysfunction-Associated Steatotic Liver Disease Is Accompanied by Increased Activities of Superoxide Dismutase, Catalase, and Carbonyl Reductase 1 and Levels of miR-200b-3p in Mouse Models. Antioxidants, 2024, 13 (11), art.1371. JCR: IF23:6.0(Q1Q1Q1) AIS23:1.012(Q2Q1Q1[Đ1]) WOS:001363472900001 EID:2-s2.0-85210449810 PMID:39594513 DOI:10.3390/antiox13111371 OBD:655295»
Šnejdrová, E.; Loskot, J.*; Věříš, A.; Kastner, P.; Andrýs, R.: Formulation study of PLGA in situ films for topical delivery of salicylates. European Journal of Pharmaceutics and Biopharmaceutics, 2024, 199 (June), art.114282. JCR: IF23:4.4(Q1) AIS23:0.714(Q2) WOS:001230330300001 EID:2-s2.0-85190355032 PMID:38614434 DOI:10.1016/j.ejpb.2024.114282 OBD:652061»
Štěrbová, K.; Raisová Stuchlíková, L.; Rychlá, N.; Kohoutová, K.; Babičková, M.; Skálová, L.; Matoušková, P.*: Phylogenetic and transcriptomic study of aldo-keto reductases in Haemonchus contortus and their inducibility by flubendazole. International Journal for Parasitology: Drugs and Drug Resistance, 2024, 25 (August), art.100555. JCR: IF23:4.1(Q1Q1) AIS23:0.980(Q1Q1) WOS:001269400700001 EID:2-s2.0-85198071200 PMID:38996597 DOI:10.1016/j.ijpddr.2024.100555 OBD:655090»
Tesař, O.; Malečová, L.; Kubíková, K.; Malý, J.*: Bezpečnost injekčních lékových forem z hlediska způsobu jejich přípravy a podání sestrami v nemocnicích: přehled literatury. Česká a slovenská farmacie, 2024, 73 (1), 27—32. DOI:10.36290/csf.2024.005 OBD:655956»
Toušková, T.; Malá, K.*: Farmaceutická péče o pacienty s akné. Česká a slovenská farmacie, 2024, 73 (3), 148—155. DOI:10.36290/csf.2024.023 OBD:655904»
Tüzün, EZ.; Pazderová, L.; Bavol, D.; Litecká, M.; Hnyk, D.; Růžičková, Z.; Horáček, O.; Kučera, R.; Grüner, B.*: Carbon-Substituted Amines of the Cobalt Bis(dicarbollide) Ion: Stereochemistry and Acid–Base Properties. Inorganic Chemistry, 2024, 63 (43), 20600—20616. JCR: IF23:4.3(Q1) AIS23:0.692(Q1) WOS:001335469800001 EID:2-s2.0-85206509869 PMID:39393080 DOI:10.1021/acs.inorgchem.4c03257 OBD:655133»
Urbánková Rathouská, J.; Jílek, P.: Imunofarmakologie. Praha: Grada, 2024, 143 p. ISBN 978-80-271-3849-4. OBD:654129»
Vagnerová, K.*; Gazárková, T.; Vodička, M.; Ergang, P.; Klusoňová, P.; Hudcovic, T.; Šrůtková, D.; Petr Hermanová, P.; Nováková, L.; Pácha, J.: Microbiota modulates the steroid response to acute immune stress in male mice. Frontiers in Immunology, 2024, 15 (February), art.1330094. JCR: IF23:5.7(Q1) AIS23:1.693(Q1) WOS:001161585700001 EID:2-s2.0-85185126281 PMID:38361932 DOI:10.3389/fimmu.2024.1330094 OBD:655743»
Váchalová, V.; Kumnova, F.; Synova, T.; Anandam, KY.; Abad, C.; Karahoda, R.; Štaud, F.*: Metformin inhibits OCT3-mediated serotonin transport in the placenta. Biomedicine & Pharmacotherapy, 2024, 179 (October), art.117399. JCR: IF23:6.9(Q1Q1) AIS23:1.141(Q2Q1) WOS:001309822200001 EID:2-s2.0-85203079448 PMID:39243433 DOI:10.1016/j.biopha.2024.117399 OBD:655765»
Wirth, F.*; Cadogan, CA.; Fialová, D.; Hazen, A.; Lutters, M.; Paudyal, V.; Weidmann, AE.; Okuyan, B.; Henman, MC.: Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical Pharmacy. International Journal of Clinical Pharmacy, 2024, 46 (2), 548—554. JCR: IF23:2.6(Q2) AIS23:0.584(Q3) WOS:001157446500002 EID:2-s2.0-85184884308 PMID:38332208 DOI:10.1007/s11096-023-01695-6 OBD:655320»
Yildirim, S.*; Karabulut, SN.; Çiçek, M.; Horstkotte, B.: Deep eutectic solvent-based ferrofluid for vortex-assisted liquid-liquid microextraction of nonsteroidal anti-inflammatory drugs from environmental waters. Talanta, 2024, 268 (February), art.125372. JCR: IF23:5.6(Q1) AIS23:0.765(Q1) WOS:001112205000001 EID:2-s2.0-85176295874 PMID:37952315 DOI:10.1016/j.talanta.2023.125372 OBD:655558»